Tech Company Financing Transactions
NeoVista Funding Round
NeoVista closed a $6 million financing round on 3/31/2006. Investors included SV Health Investors and The Carlyle Group.
Transaction Overview
Company Name
Announced On
3/31/2006
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors
SV Health Investors (James Garvey)
The Carlyle Group (Ryan Schwarz)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
38875 Cherry St.
Newark, CA 94560
USA
Newark, CA 94560
USA
Phone
Website
Email Address
Overview
NeoVista, Inc. is developing a novel therapy to treat wet Age-Related Macular Degeneration (AMD) utilizing a Strontium-90 isotope. The delivery is made through a minimally invasive surgical procedure.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Hendrick
VP - Finance
Tim Dumke
VP - R & D
David Gyorke
VP - Regulatory Affairs
Anil Patel
VP - Sales
Tony Moses
Browse more venture capital transactions:
Prev: 3/31/2006: UNX Holdings venture capital transaction
Next: 3/31/2006: Zenasis Technologies venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs